CONFERENCES

      Basel Computational Biology Conference

      Basel Computational Biology Conference, or [BC]2, is an annual conference held in Basel, Switzerland that brings together researchers, computer scientists, and other professionals interested in the development and use of computational methods in biology. The conference covers a wide range of topics in computational biology, including algorithm development, data analysis, and modeling. The aim of the conference is to provide a forum for sharing the latest research findings and to foster collaborations among researchers working in this rapidly evolving field.

      13th [BC]2 Conference 2017

      Date

      Sep 12, 2017 - Sep 15, 2017

      Location

      Basel, Switzerland

      The 13th [BC]2 - the Basel Computational Biology Conference - includes presentations on cutting-edge research in computational biology and bioinformatics and features workshops, tutorials, poster sessions, as well as keynote lectures by international experts.

      See related posters

      PMIScience.com is operated by Philip Morris International for the purpose of publishing and disseminating scientific information about Philip Morris International’s efforts in support of its smoke-free product portfolio. This site is a global site for use by scientists, the public health and regulatory communities, and other stakeholders with an interest in tobacco policy. The purpose of this site is not advertising or marketing, nor is it directed at any specific market. It is not intended for use by consumers. New tobacco products sold in the United States are subject to FDA regulation; therefore the content of this site is not intended to make, and nor should it be construed as making, any product related claims in the United States without proper FDA authorization. ​
      ​
      Reduced Risk Products ("RRPs”) is the term we use to refer to products that present, are likely to present, or have the potential to present less risk of harm to smokers who switch to these products versus continuing smoking. PMI has a range of RRPs in various stages of development, scientific assessment and commercialization. All of our RRPs are smoke-free products that deliver nicotine with far lower quantities of harmful and potentially harmful constituents than found in cigarette smoke.